FDA 510(k), UKCA, and CE mark-cleared solution for prostate MRI based on Artificial Intelligence.

AI Solution to increase diagnostic accuracy

QP-Prostate® optimizes clinical workflow and supports accurate decision-making for prostate MRI exams.This solution provides automated prostate gland segmentation that generates quantitative and meaningful insights and standardizes the reporting of prostate MRI.

The AI-powered tool integrates directly with PACS and streamlines tasks, providing quantifiable insights with significant clinical and economic benefits.

Book a demo


Structured radiology reports

QP-Prostate creates structured reports including quantitative information following PI-RADS v2.1 guidelines. The solution automates prostate gland volume calculation powered by AI, and identifies quantitative imaging biomarkers, ensuring precise measurements for diagnosis.



QP-Prostate performs automated diffusion and perfusion analysis to extract clinically meaningful quantitative information from the MRI examination.


AI-based segmentation

QP-Prostate’s AI algorithm, based on Convolutional Neural Networks (CNNs), automatically identify prostate anatomy to segment each prostate subregion: including the transition zone, the peripheral zone, and seminal vesicles, as well as the prostate zones defined in the PI-RADS v2.1 guidelines.




QP-Prostate automatically runs processing steps, such as automatic registration, motion correction, and spatial smoothing to improve image quality and minimize heterogeneity. Its web-based DICOM viewer allows users to customize and adjust these processing steps.


PACS to Cloud

QP-Prostate automatically sorts and matches prostate MRI cases without disrupting radiology workflows. The tool supports both biparametric (T2+DWI) and multiparametric (T2+DWI+DCE) MRI exams.

The challenge

Clinical Overview

Prostate cancer is one of the most common types of cancer among men and is the second leading cause of cancer death in men worldwide. More than 1.4 million men are diagnosed annually with prostate cancer. Prostate MRI, in conjunction with targeted biopsy, improves the identification of clinically significant cancer while reducing unnecessary interventions.

User pain points
  1. Reducing the number of unnecessary biopsies.
  2. Time-consuming reading and reporting of MRI exams
  3. Shortage of specialized prostate radiologists given the increase in the number of prostate MRI exams.
  4. Ensuring quality and reproducibility of prostate exams.
  5. Standardizing the prostate MRI reporting process.
  6. Accurate interpretation of prostate MRI exams according to PI-RADS guidelines.

The solution

QP-Prostate is state-of-the-art medical software that streamlines reading of prostate MRI exams by providing automated, quantitative image analysis. The solution provides apparent diffusion coefficient (ADC) heat maps, perfusion pharmacokinetics, and automatic segmentation of the whole prostate gland.

QP-Prostate outputs can be visualized on DICOM workstations or integrated directly in PACS. It provides standardized structured reports following PI-RADS V2.1 guidelines for  patient friendly reports.

  • The output of QP-Prostate is provided in DICOM format and can be used for aiding in fusion-biopsy targeting.

The QP-Prostate viewer allows for ROI management and annotation of whole gland segmentation. The structured report offers pre-populated information, technical details, prostate gland volume, PI-RADS scoring template, automated ROI metrics, and an efficient way to enter radiology conclusions with image selection. The output of QP-Prostate® is provided in DICOM format and can be used for fusion-biopsy targeting for more accurate and precise biopsy results.



Interested on learning more about QP-Prostate?

Book a demo